|
Upadacitinib 15 MG [Rinvoq] Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Rinvoq
Other1 trial
Portland, Oregon1 trial
A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
Oregon Health and Science University
Phase 4
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.